Group One Trading, L.P. Sage Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.68 Billion
Q1 2024

A detailed history of Group One Trading, L.P. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 36,389 shares of SAGE stock, worth $392,273. This represents 0.03% of its overall portfolio holdings.

Number of Shares

36,389

Previous 1,981 1736.9%

Holding current value

$392,273

Previous $42,000 1521.43%

% of portfolio

0.03%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$18.62 - $26.95 $640,676 - $927,295	34,408 Added 1736.9%	36,389 $681,000
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $614,881 - $800,425	-35,958 Reduced 94.78%	1,981 $42,000
Q3 2023 Nov 09, 2023	BUY	$16.75 - $48.98 $427,577 - $1.25 Million	25,527 Added 205.66%	37,939 $780,000
Q2 2023 Aug 09, 2023	SELL	$40.65 - $59.54 $82,478 - $120,806	-2,029 Reduced 14.05%	12,412 $583,000
Q1 2023 May 12, 2023	SELL	$37.27 - $46.57 $212,364 - $265,355	-5,698 Reduced 28.29%	14,441 $605,000

Q4 2022 Feb 09, 2023	SELL	$32.2 - $43.61 $42,922 - $58,132	-1,333 Reduced 6.21%	20,139 $768,000
Q3 2022 Nov 09, 2022	BUY	$32.28 - $43.27 $210,271 - $281,860	6,514 Added 43.55%	21,472 $841,000
Q2 2022 Aug 11, 2022	BUY	$27.52 - $37.99 $398,599 - $550,247	14,484 Added 3055.7%	14,958 $483,000
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $57,581 - $85,706	-1,875 Reduced 79.82%	474 $16,000
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $259,420 - $329,770	-7,000 Reduced 74.87%	2,349 $100,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $3.26 Million - $4.64 Million	-80,926 Reduced 89.64%	9,349 $414,000
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $4.62 Million - $6.68 Million	84,212 Added 1388.95%	90,275 $5.13 Million
Q1 2021 May 12, 2021	BUY	$70.65 - $96.76 $428,350 - $586,655	6,063 New	6,063 $454,000
Q4 2020 Feb 10, 2021	SELL	$58.41 - $89.06 $636,552 - $970,575	-10,898 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $665,689 - $1.01 Million	-16,185 Reduced 59.76%	10,898 $666,000
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $181,208 - $301,316	-6,983 Reduced 20.5%	27,083 $1.13 Million
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $890,825 - $2.63 Million	34,066 New	34,066 $978,000
Q4 2019 Feb 10, 2020	SELL	$60.18 - $154.77 $218,272 - $561,350	-3,627 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $508,831 - $688,984	3,627 New	3,627 $509,000
Q1 2019 May 13, 2019	SELL	$89.33 - $163.65 $729,468 - $1.34 Million	-8,166 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$81.94 - $139.71 $669,122 - $1.14 Million	8,166 New	8,166 $782,000
Q4 2017 Feb 09, 2018	SELL	$60.72 - $167.34 $110,692 - $305,060	-1,823 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$61.4 - $88.52 $343,164 - $494,738	-5,589 Reduced 75.4%	1,823 $114,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,412	7,412 $590,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Sage Therapeutics, Inc. Transaction History